These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2563772)

  • 21. Effects of subchronic minaprine on dopamine release in the ventral striatum and on immobility in the forced swimming test.
    Imperato A; Obinu MC; Cabib S; Cestari V; Puglisi-Allegra S
    Neurosci Lett; 1994 Jan; 166(1):69-72. PubMed ID: 8190361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors.
    Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C
    J Med Chem; 1998 Dec; 41(25):5070-83. PubMed ID: 9836623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of new [1,2,4]triazolo[4,3-b]pyridazines. Part 12: Studies in the field of pyridazine compounds.
    Kosáry J; Kasztreiner E; Lázár A; Sóti M
    Pharmazie; 1983 Jun; 38(6):369-71. PubMed ID: 6611639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N; Ravic M; Bizière K
    Drugs Exp Clin Res; 1987; 13(7):435-42. PubMed ID: 3308390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and SAR of adatanserin: novel adamantyl aryl- and heteroarylpiperazines with dual serotonin 5-HT(1A) and 5-HT(2) activity as potential anxiolytic and antidepressant agents.
    Abou-Gharbia MA; Childers WE; Fletcher H; McGaughey G; Patel U; Webb MB; Yardley J; Andree T; Boast C; Kucharik RJ; Marquis K; Morris H; Scerni R; Moyer JA
    J Med Chem; 1999 Dec; 42(25):5077-94. PubMed ID: 10602693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3-heptylamino-5-phenylpyridazine derivatives as analogues of Acyl-CoA: cholesterol acyltransferase inhibitors containing the N-heptyl-N'-arylureidic moiety.
    Gelain A; Barlocco D; Kwon BM; Jeong TS; Im KR; Legnani L; Toma L
    Arch Pharm (Weinheim); 2006 Dec; 339(12):645-51. PubMed ID: 17109461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Syntheses and in vitro evaluation of 4-(2-aminoethyl)-2(3H)-indolones and related compounds as peripheral prejunctional dopamine receptor agonists.
    DeMarinis RM; Gallagher G; Hall RF; Franz RG; Webster C; Huffman WF; Schwartz MS; Kaiser C; Ross ST; Wilson JW
    J Med Chem; 1986 Jun; 29(6):939-47. PubMed ID: 3712384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antidepressant activity of substituted (omega-aminoalkoxy)benzene derivatives.
    Kikumoto R; Tobe A; Tonomura S
    J Med Chem; 1981 Feb; 24(2):145-8. PubMed ID: 7205881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 7-(Aminoacyl) and 7-(aminoalkyl) derivatives of 1,2,6,7-tetrahydroindolo[1,7-ab][1,5]benzodiazepines as potential antidepressant agents.
    Glamkowski EJ; Fortunato JM; Geyer HM
    J Med Chem; 1980 Dec; 23(12):1380-6. PubMed ID: 6109027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of 3-(2-morpholinoethylamino)-4-methyl-6-phenyl pyridazine dihydrochloride (minaprine) on plasma cortisone levels of physostigmine treated rats.
    Laborit H; Bonifacj JF
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):63-7. PubMed ID: 6729250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
    Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
    Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the antidepressant minaprine on both forms of monoamine oxidase in the rat.
    Kan JP; Mouget-Goniot C; Worms P; Biziere K
    Biochem Pharmacol; 1986 Mar; 35(6):973-8. PubMed ID: 3954800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: synthesis and antidepressant activity.
    Yardley JP; Husbands GE; Stack G; Butch J; Bicksler J; Moyer JA; Muth EA; Andree T; Fletcher H; James MN
    J Med Chem; 1990 Oct; 33(10):2899-905. PubMed ID: 1976813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Synthesis, antisecretory, and anti-ulcer activity of new 5-arylidene-2-ureidoalkyl-3-pyridazinones].
    Rubat C; Coudert P; Couquelet J; Bastide P; Bastide J
    Farmaco Sci; 1988 Dec; 43(12):1035-44. PubMed ID: 3248593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and pharmacological activities of 2-substituted 4-phenylquinolines as potential antidepressant drugs.
    Alhaider AA; Abdelkader MA; Lien EJ
    J Med Chem; 1985 Oct; 28(10):1394-8. PubMed ID: 4045918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia.
    Haleem DJ
    J Coll Physicians Surg Pak; 2006 Aug; 16(8):556-62. PubMed ID: 16899192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and structure-activity relationships of a series of aminopyridazine derivatives of gamma-aminobutyric acid acting as selective GABA-A antagonists.
    Wermuth CG; Bourguignon JJ; Schlewer G; Gies JP; Schoenfelder A; Melikian A; Bouchet MJ; Chantreux D; Molimard JC; Heaulme M
    J Med Chem; 1987 Feb; 30(2):239-49. PubMed ID: 3027337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biphenyl versus phenylpyridazine derivatives: the role of the heterocycle in a series of acyl-CoA:cholesterol acyl transferase inhibitors.
    Gelain A; Barlocco D; Kwon BM; Jeong TS; Im KR; Legnani L; Toma L
    J Med Chem; 2008 Mar; 51(5):1474-7. PubMed ID: 18284184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioisosteric approach in the design of new dopaminergic/serotonergic ligands.
    Soskić V; Joksimović J
    Curr Med Chem; 1998 Dec; 5(6):493-512. PubMed ID: 9873112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
    Arnt J; Hyttel J; Overø KF
    Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.